Hanshang Group Co Ltd

Hanshang Group's capital structure shows a debt-to-equity ratio of 0.65, indicating moderate leverage. The company's liquidity position is weak, with a current ratio of 0.44, suggesting potential short-term liquidity constraints. Free cash flow is negative at -1.94 million CNY, and operating cash flow is 192.78 million CNY, highlighting a mismatch between operating performance and capital outflows. Profitability metrics are negative, with a return on equity of -0.88% and a return on assets of -0.41%, both significantly below industry norms for pharmaceutical companies. The company reported a net loss of 14.59 million CNY and an operating loss of 9.73 million CNY, indicating operational inefficiencies. The company's revenue is distributed across three segments: Pharmaceuticals and Medical Devices, Commercial Operations, and Exhibition Operations. However, the financial snapshot does not provide segment-specific revenue figures, making it difficult to assess concentration risk or growth drivers. The company's geographic exposure is primarily domestic, with no disclosed international operations. Growth trajectory is uncertain, as the company reported a revenue of 1.18 billion CNY in the latest period. Analyst estimates for revenue and EPS are significantly lower than the company's reported figures, suggesting potential downward revisions in expectations. The negative net income and operating income indicate a lack of consistent profitability, which could hinder long-term growth. Risk factors include medium liquidity risk and a negative net cash position after subtracting total debt. The company's dilution risk is low, with no near-term pressure from share issuance. However, the negative free cash flow and capital expenditure of -60.50 million CNY suggest potential future financing needs. Recent events include the latest financial filing, which disclosed a net loss and negative operating income. No recent earnings call transcripts or significant regulatory filings were provided in the input data, limiting insight into management's strategic direction or operational updates.